Board Meeting19 May 2026, 03:21 pm
Orchid Pharma Board Meeting on May 25, 2026
AI Summary
Orchid Pharma Ltd has scheduled a Board of Directors meeting on May 25, 2026, to consider and approve the Audited Financial Results (Standalone & Consolidated) for Quarter-IV and the financial year 2025-26, which ended on March 31, 2026. The trading window for dealing in the company's securities has been closed from April 01, 2026, and will remain closed until 48 hours after the declaration of the said financial results.
Key Highlights
- Orchid Pharma's board will meet on May 25, 2026, to approve audited financial results.
- The results are for Quarter-IV and Financial Year 2025-26 ending March 31, 2026.
- Trading window closed from April 1, 2026, until 48 hours post results declaration.
Price Impact
More from ORCHIDPHAR